DelMar Pharmaceuticals (NSDQ:DMPI) closed its $9 million public offering today. Earlier this week, the company priced 2.8 million shares and warrants to purchase an aggregate of 2.1 million shares of common stock at $3.25 apiece.
The offering’s warrants have an exercise price of $3.50 per share and have an term of exercise of 5 years, according to the Menlo Park, Calif.-based company. DelMar plans to use the offering’s $8 million in net proceeds for general corporate purposes.
Get the full story at our sister site, Drug Delivery Business News.
The post DelMar closes $9m public offering appeared first on MassDevice.